Tag Archives: Global Alzheimer’s and Dementia Action Alliance (GADAA)

More on the Disproportionately High Impact of Dementia Upon Women (GADAA)

Posted on September 25, 2017 by Dementia and Elderly Care News

Summary Women comprise roughly 65% of people with dementia in the UK. They are disproportionately affected by the condition in terms of having to assume caring responsibilities. The main section headings in this report comprise: Chapter 1: Key Challenges. An … Continue reading →

Research Towards a World Without Dementia: Marking World Alzheimer’s Day / World Alzheimer’s Month 2017 (Alzheimer’s Disease International / Department of Health)

Posted on September 23, 2017 by Dementia and Elderly Care News

Summary Information is available from Alzheimer’s Disease International (ADI) concerning World Alzheimer’s Month (September) and World Alzheimer’s Day 2017, which was on September 21st 2017. The theme for this year’s World Alzheimer’s Month campaign is again “Remember Me”. The UK … Continue reading →

Posted in Charitable Bodies, Commissioning, Department of Health, Diagnosis, In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged 70th World Health Assembly Adopted Global Action Plan on Dementia, Ageing Population, Awareness, Awareness Campaigns, Awareness Raising, Carey Mulligan, Carey Mulligan: UK Global Dementia Friends Ambassador, Collaborative Research, Collaborative Working, Community and Voluntary Sector, Dementia Awareness Campaigns, Dementia Awareness Raising, Dementia Friends, Dementia Friends Programme, Dementia Research, Dementia Research Institute (DRI), Dementia-Friendly Communities, Dementia-Friendly Environments, Dementia-Friendly Organisations, Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, First G8 Dementia Summit, Former Health Secretary Jeremy Hunt, G8 Dementia Summit, G8 Dementia Summit Declaration, G8 Dementia Summit: Global Action Against Dementia, Global Action Against Dementia, Global Action Plan on Dementia, Global Alzheimer’s and Dementia Action Alliance, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Context, Global Dementia Friends Ambassadors, Global Leadership, International Collaborations, International Dementia Research, Leadership for Compassionate Care, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Partnership Working, Reducing Stigma, Research and Development, Research and Innovation, Research Commitment, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Stigma of Dementia, Stigma-Free Environments, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), Voluntary Organisations, WHO Global Action Plan on the Public Health Response to Dementia 2017-2025, World Alzheimer's Month 2017 (Remember Me), World Alzheimer’s Day 2017, World Alzheimer’s Month 2017, Yuichiro Miura: Japan’s Dementia Supporters Ambassador | Leave a comment

Challenges in Developing Disease-Modifying Treatments for Dementia (Department of Health)

Posted on July 23, 2015 by Dementia and Elderly Care News

Summary Raj Long, the Senior Regulatory Officer at the Bill & Melinda Gates Foundation, explores the problems in developing treatments for dementia. The independent “Finding a Path for the Cure for Dementia” report is a contribution to the G8 Dementia … Continue reading →

Posted in Charitable Bodies, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Models of Dementia Care, Patient Care Pathway, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged Academia-Industry Partnerships, Academic Research, AIFA: Italian Medicines Agency, Attrition Analysis, BfArM: Federal Institute of Drugs and Medical Devices, BfArM: Federal Institute of Drugs and Medical Devices (Germany), Bill and Melinda Gates Foundation, Biopharmaceutical Companies, Burden of Dementia, Canada, CEOi: Global CEO Initiative on Alzheimer’s Disease, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Composite End Points, Consistent Global Development Pathways, Cross-Sector Partnerships, CTEG: Clinical and Technical Expert Group, Danish Health and Medicines Authority, Data Sharing, Dementia Challenge, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Denmark, Department of Health Dementia Challenge, Diagnosis and Referral, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DKMA: Danish Health and Medicines Authority, Drug Discovery Programmes, Drug Identification, Drug Regulation, Drug-Development Pipeline, Eli Lilly Inc., Eli Lilly’s UK Dementia Research Centre, EMA: European Medicines Agency, European Medicines Agency, European Union, FIH: First in Humans, Financial Incentives, First Global Ministerial Conference on Global Action Against Dementia, Food and Drug Administration, G20 Countries, G7 Countries, G8 Dementia Summit: Global Action Against Dementia, G8 Summit, Gaps in the Basic Science, Germany, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Government Research Funding, Health Canada, IAP Steering Committee, IDAP Steering Committee, IDAP: International Dementia Advisory Platform, IFPMA: International Federation of Pharmaceutical Manufacturers & Associations, Incentives and Investment, Incentives for Drug Development, Independent Safety Review Committee, Integrated Development Pathway, International Collaborations, International Dementia Advisory Platform (IDAP), International Dementia Research Inventories, International Programmes, Italian Medicines Agency, Italy, Japan, Japan: Pharmaceuticals and Medical Devices (Japan), Knowledge Translation, MEB: Medicines Evaluations Board, Medicines and Healthcare Products Regulatory Agency, Medicines Evaluation Board Netherlands, MHRA: Medicines and Healthcare Products Regulatory Agency, Modelling and Extrapolation, Multilateral Cooperation, Multilateral Regulator Cooperation, Netherlands, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, OHE: Office of Health Economics, Open Access Databases, Open Access Knowledge Resources, Open Access Research, Open Science, Organisation for Economic Co-operation and Development (OECD), Organisation for Economic Co-operation and Development (OECD) Countries, Organisation for Economic Cooperation and Development, Partnership, Partnership and Collaboration, Partnership Working, Patient Viewpoint, Philanthropic Funding, Pipeline Databases, PMDA: Pharmaceutical and Medicines Devices Agency, Public-Private Partnership (PPP), Quantifiable Reproducible Outcome Measures, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Reasons for Termination of Trials, Regulator Perspectives, Regulatory Agencies, Regulatory Experts, Research and Developers’ Status Quo, Research and Development, Research and Innovation, Research Commitment, Research Funding, Research Status Quo, Resource and Incentives, Risk Benefit Balance, Standardisation and Validation of Cognitive Endpoints, Swiss Medic, Switzerland, United States, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO) | Leave a comment

Dementia 2015 UK Policy Report: Improving the Quality of Life for People with Dementia (Alzheimer’s Society)

Posted on July 7, 2015 by Dementia and Elderly Care News

Summary The Alzheimer’s Society’s fourth annual report exploring the quality of life for people with dementia (and their families and carers) in England, Wales and Northern Ireland, is entitled “Dementia 2015: Aiming higher to transform lives is in England”. This … Continue reading →

Posted in Acute Hospitals, Alzheimer's Society, Antipsychotics, Charitable Bodies, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Northern Ireland, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest, Wales | Tagged 2015 General Election Dementia Manifesto (All Party Parliamentary Group on Dementia), Active Lifestyle, Addressing Dementia: The OECD Response (2015), All Party Parliamentary Group on Dementia Manifesto for 2015 General Election, Alternatives to Antipsychotic Medication, Alzheimer's Society Policy Reports: Dementia 20xx Series, Alzheimer's Society: Dementia Friendly Communities Programme, Alzheimer’s Society Dementia Advisers, Alzheimer’s Society National Dementia Helpline, Alzheimer’s Society Public Policy Team, Alzheimer’s Society’s Carer Information and Support Programme (CrISP), Alzheimer’s Society’s Research Network, Alzheimer’s Society’s Supporting Diagnosis Project, APPG on Dementia, APPG on Dementia Manifesto 2015, Asda, Assessment of Quality of Life, Attributable Cost of Dementia, Aviva, Awareness and Understanding, Awareness Raising, Balancing Risk and Choice, Barbara Pointon’s Web of Care, Baroness Sally Greengross (APPG on Dementia), Barriers to Involvement, Barriers to Joined-Up Care, Barriers to Support, Barriers: Discrimination, Barriers: Lack of Continuity of Care, Barriers: Lack of Support for Carers, Blackfriars Consensus Statement, Burden of Dementia (Statistics), Care and Support, Care and Support Services, Care Homes, Caregiver Support, Carer Burden in Dementia, Carer Information and Support Programme, Carer Information and Support Programme (CrISP), Carer Support, Carers’ Health and Wellbeing, Central Lancashire’s Pathway of Post-Diagnostic Support Services, Challenge on Dementia 2020, Co-Morbidities and Dementia, Commissioners of Services, Commissioning Support Services, Community Support, Community Support Services, Cracks in the Pathway (CQC), Crawley Dementia Alliance, Dementia 2015 UK Policy Report, Dementia 2015: Aiming Higher to Transform Lives, Dementia Action Alliance (DAA), Dementia Adviser Service, Dementia Advisers, Dementia Advisor Service, Dementia Advisors, Dementia Awareness, Dementia Co-Morbidities, Dementia Diagnosis and Care in England, Dementia Diagnosis Rates, Dementia Friendly Communities Champion Group, Dementia Friendly Communities Programme, Dementia Friendly Swimming Project: Amateur Swimming Association (ASA), Dementia Friends, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Dementia-Friendly Businesses, Dementia-Friendly Care Homes, Dementia-Friendly Cities, Dementia-Friendly Communities, Dementia-Friendly Health and Care Settings, Dementia-Friendly Hospitals, Dementia-Friendly Organisations, Dementia-Friendly Towns, Dementia-Friendly Workplaces, Deprivation of Liberty Safeguards (DoLS), Diagnosis and Referral, Disease-Modifying Therapies for Dementia, EasyJet, Focused Intervention Training and Support (FITS), Forget Me Not Dementia Unit (Warrington Hospital), G8 Summit, Global Alzheimer’s and Dementia Action Alliance (GADAA), Happiness and Wellbeing, Health and Quality of Life, Health and Social Care Reform, Health and Wellbeing, Health Care Support Received by People with Mental Health Problems, Health Commissioners, Health Wellbeing and Independence, Healthy Lifestyles, Home Retail Group (Argos and Homebase), Impact of Dementia (Statistics), Improving Dementia Education and Awareness, Improving the Quality of Life for People with Long Term Conditions, Inadequate Homecare Training, Increasing Wellbeing, Integrated Services in Tower Hamlets, Involvement and Participation, John's Campaign, Living Well with Dementia, Living Well with Dementia Research, Lloyds Banking Group, Loneliness and Social Isolation, Marks and Spencer, National Dementia Helpline, New Models of Care, NHS England’s Five Year Forward View, NHS England’s New Models of Care Programme, NHS Five Year Forward View (5YFV), Organisational and Cultural Barriers, Over-Complexity, Participation in Research, Patient Reported Outcome Measures (PROMs) in Dementia Study, Patient Reported Outcome Measures in Dementia, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Prevalence of Dementia, Prime Minister’s Challenge On Dementia 2020, Public Health England, Quality of Care Across the Course of Dementia, Quality of Life, Quality of Life (Carers), Quality of Life for People With Dementia, Quality of Life Promotion, Quality of Life Research, Reducing Antipsychotic Prescriptions in Dementia, Reducing Complexity, Reducing Social Isolation: Side by Side, Right to Know Campaign, Risk Management, Risk Management Assessment, Risk Stratification, Social Isolation, St Gregory’s High School (Warrington), Support for New Models of Care (New Deal), Support Services, Supporting Healthy Lifestyles, Supporting People to Live Well With Dementia, Supreme Court Judgment (March 2015) on Deprivation of Liberty Safeguards (DoLS), Swimming With Dementia, Systems Complexity, Tower Hamlets, Web of Care, Workforce Development, Workforce Training, World Dementia Council | Leave a comment

Women and Dementia (Alzheimer’s Disease International / GADAA)

Posted on June 23, 2015 by Dementia and Elderly Care News

Summary This year’s Alzheimer’s Disease International (ADI) World Alzheimer Report is a thorough international review of the disproportionate impact of dementia on women. It examines three aspects of the differential effect of gender on: Women living with dementia. Women caring … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged 70th World Health Assembly (May 2017), ADI’s World Alzheimer Reports, Advice and Information, Ageing and Society, Ageing Population, Ageing Workforce, Association for Dementia Studies: University of Worcester, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Burden on Caregivers, Care Competencies for Health and Care Staff and Professionals Working With People Living With Dementia, Caregiver Burden, Carer Awareness, Carer Experience, Carer Fatigue, Carer Support, Carers and Families, Commissioning for Carers, Convention on the Elimination of All Forms of Discrimination against Women (CEDAW), Dementia Prevalence Projections: HIC Countries, Dementia Prevalence Projections: HIC Countries (High Income Countries), Dementia Prevalence Projections: LMIC Countries, Dementia Prevalence Projections: LMIC Countries (Low and Middle Income Countries), Differential Impact of Dementia (Gender-Related), Disease Burden, Disproportionate Burden of Dementia on Women, Disproportionate Impact of Dementia on Women, Elizabeth Peel: Institute of Health and Society, Family Carers, Female to Male Sex Ratios in Ageing, GADAA: Global Alzheimer’s and Dementia Action Alliance, Gender (Sex), Gender and Inequalities in Health in Later Life, Gender Issues of Living With or Caring For Persons With Dementia, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Burden of Dementia, Global Plan of Action on the Public Health Response to Dementia 2017–2025, Impact of Caring on Ability to Work, Impact of Caring on Carers, Informal Workforce, Information and Advice Services, Information and Support for Carers, Information and Support for Patients and Carers, Institute of Health and Society, Institute of Health and Society: University of Newcastle, Lesbian Gay Bisexual or Transgender (LGBT), LMICs, Long-Term Impact of Dementia on Women as Family and Formal Caregivers, Men vs. Women (Diseease Prevalence), Migration and Care Work, Nursing Workforce, Older Carers, Prevalence of Dementia, Prevalence of Unpaid Care, Professor Dawn Brooker, Recorded Dementia Prevalence, Red & Yellow Care, Rosie Erol: Institute of Health and Society, Skills and Competencies, University of Worcester, University of Worcester: Association for Dementia Studies, Unpaid Caregivers (Carers), Unpaid Carers, USAgainstAlzheimer’s Network, WHO Global Action Plan, Women and Dementia, Women and Dementia: ADI’s Global Overview (2015), Women and Dementia: Global Research Review, Women in Dementia Care Workforce, WomenAgainstAlzheimer’s, Worcester University, Workforce Competencies | Leave a comment

International Meeting of Regulators on Challenges of Dementia Research and Drug Development (MHRA / Department of Health)

Posted on May 26, 2015 by Dementia and Elderly Care News

Summary The Medicines and Healthcare Products Regulatory Agency (MHRA) took part in an international workshop with other regulators, and has released a statement of intent about how to support the development of drugs for dementia. This work is in support … Continue reading →

Posted in Department of Health, For Doctors (mostly), For Researchers (mostly), International, Pharmacological Treatments, Quick Insights, World Health Organization (WHO) | Tagged Accelerating Alzheimer's Research and Drug Development, Attrition Analysis, Bill and Melinda Gates Foundation, Clinical Trial Efficiency, Composite End Points: Development of Standardised and Validated Endpoint Components, Coordinated Regulatory Action, Danish Health and Medicines Authority, Dementia Research, Department of Health’s Integrated Development Initiative, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Development for Alzheimer's Disease, Drug Regulation, Drug-Development Pipeline, European Medicines Agency, Expediting Regulatory Approval Procedures: Balancing Benefits and Risks, Federal Institute for Drugs and Medical Devices, First Global Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia, G7 Global Dementia Summit, G8 Dementia Summit, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Leadership, Global Ministerial Conference on Global Action Against Dementia (WHO), Global Outlook, Global Regulatory Efficiency and Consistency, Health Canada, Incentives, Incentives for Drug Development, International Federation of Pharmaceutical Manufacturers and Associations, Italian Medicines Agency, Market Failure (Dementia Research and Drug Development), Medicines and Healthcare Products Regulatory Agency, Medicines and Healthcare Products Regulatory Agency (MHRA), Medicines Evaluation Board, Multilateral Cooperation: Reducing Unnecessary Testing Replication and Methodology Testing, Office for Life Sciences, Pharmaceutical and Medicines Devices Agency (Japan), Pharmaceutical Regulators, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Regulation, Regulators, Regulatory Barriers, Regulatory Research Dementia Workshop, Regulatory System, Removing Regulatory Barriers, Research and Innovation, Resource and Incentives, Swissmedic, Translational Research, US Food and Drug Administration, WDC: World Dementia Council, WHO: World Health Organization, World Dementia Council | Leave a comment

New World Dementia Council Website (WDC)

Posted on May 25, 2015 by Dementia and Elderly Care News

Summary An announcement has been released from the pre-existing World Dementia Council (WDC) site that a fresh World Dementia Council website (on the WordPress platform) has been launched. The older site will no longer be updated. The benefits of this … Continue reading →

Dementia Care, Patient Experience and Risk Reduction Are Priorities for World Dementia Council (Department of Health / Dementia Challenge / WDC)

Posted on November 30, 2014 by Dementia and Elderly Care News

Summary It has been agreed at the World Dementia Council‘s third meeting in London (held at the Foreign and Commonwealth Office on Friday October 17th 2014) that dementia care (i.e. health and social care) and risk reduction should be added … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest, World Health Organization (WHO) | Tagged Achieving Dementia Friendly Acute care, Alzheimer's Research UK, Alzheimer’s Disease International (ADI), Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Challenge on Dementia (David Cameron), Collaborative Projects, Community Rehabilitation, Continuity Plans (WDC and GAAD Agenda), Conversion to Dementia From Prodromal Disease, Cross-Sector Partnerships, Danish Health and Medicines Authority, Dementia Alliance International, Dementia Awareness, Dementia Challenge, Dementia Risk Factors, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health's Digital Health Blog, Digital Engagement, Dr Kiyoshi Kurokawa: Professor of the National Graduate Institute for Policy Studies and Science Advisor to the Cabinet of Japan, Dr Margaret Chan: WHO Director-General, European Medicines Agency, Experiences, Experiences of Diagnosis, Experts by Experience, F ederal Institute for Drugs and Medical Devices Germany, Finance and Incentives, Fourth World Dementia Council Meeting (February 2015), G7 Countries, G7 Global Dementia Summit, G8 Dementia Summit, GADAA Toolkit: Global Alzheimer’s and Dementia Action Alliance, Geoff Huggins: Scottish Government, Global Action Against Dementia, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Harry Johns: President and CEO of Alzheimer’s Association, Harry Johns: World Dementia Council Member, Health Canada, Healthy Behaviours, Healthy Communities, Healthy Lifestyles, Hilary Doxford: World Dementia Council Member, Innovation in Care and Prevention (Japan Legacy Event), Innovative Technology, Integrated Development, International Collaborations, International Dementia Research Inventories, International Programmes, Italian Medicines Agency, Japan Legacy Event, Japan Legacy Event: Innovation in Care and Prevention, Japan’s G7 Legacy Event on Dementia Care and Prevention, JP Morgan, Kate Swaffer: Chair of Dementia Alliance International, Legacy Event in March 2015, Lifestyle Risk Factors, Lived Experience, Living Well with Dementia, Living Well with Dementia Research, Maintaining Independence, Medicines and Healthcare Products Regulatory Authority UK, Medicines Evaluation Board Netherlands, Modifiable Risk Factors, Open Science and Data, Organisation for Economic Co-operation and Development (OECD), Organisation for Economic Cooperation and Development, Partnership and Collaboration, Partnership Working, Patient Experience, Personal Experience of Dementia, Peter Paniccia, Pharmaceutical and Medical Devices Agency Japan, Pharmaceutical Industry, Pharmaceutical Regulators, Pre-Clinical Fund, Pre-Clinical Space, Prescribed Disengagement, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Prodromal Alzheimer's Disease, Professor Martin Rossor: Former Director of the NIHR Dementia and Neurodegenerative Disease Research Network (DeNDRoN), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Martin Rossor: UCL Institute of Neurology, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Reablement, Reablement Services, Regaining Independence, Rehabilitation, Rehabilitation and Self Management, Research and Innovation, Resource and Incentives, Risk Factors, Risk Factors for Alzheimer's Diseease, Risk Reduction (Formerly Termed Prevention by WDC), Science and Innovation, Service User Experience, Sir Mark Walport, Sir Mark Walport (Wellcome Trust), Specialist Rehabilitation Services, Staying Independent, Support for Carers, Sustainable Care, Tackling Barriers to Innovation, Third Global Dementia Legacy Event, Third Global Dementia Legacy Event (Japan: November 2014), Third World Dementia Council Meeting Communique, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, US Food and Drug Administration, WDC Dementia Risk Reduction Statement, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO), World Health Organization (WHO) | Leave a comment

Tag Archives: Global Alzheimer’s and Dementia Action Alliance (GADAA)

Research Towards a World Without Dementia: Marking World Alzheimer’s Day / World Alzheimer’s Month 2017 (Alzheimer’s Disease International / Department of Health)

International Meeting of Regulators on Challenges of Dementia Research and Drug Development (MHRA / Department of Health)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites